Insider · CIK 0001756235
Knight Therapeutics Inc
Files at SNYRQ (Synergy CHC Corp.). First filing -, latest -.
In brief
Knight Therapeutics Inc files SEC Form 4 as 10% owner at SNYRQ (Synergy CHC Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Knight Therapeutics Inc has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2025 | SNYRQ Synergy CHC Corp. | POpen-market purchase Pre-Funded Common Stock Purchase Warrantderivativeindirect: See footnote | +428,570 | $0.00 | $0 | 428,570 | Jun 13, 2025 |
Questions about Knight Therapeutics Inc
Answered from the filings on this page, as of the latest one.
Is Knight Therapeutics Inc buying or selling?
Knight Therapeutics Inc has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Knight Therapeutics Inc's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Knight Therapeutics Inc has 0.
Where does Knight Therapeutics Inc file Form 4?
Knight Therapeutics Inc has filed Form 4 at SNYRQ (Synergy CHC Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.